DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8chckw/cas_norethindrone) has announced the addition of the "CAS Norethindrone World Consumption Report" report to their offering.
This CAS Norethindrone World Consumption Report provides data on the net consumption of CAS 68-22-4 - Norethindrone Substance(s) in each of the countries listed. The Substance(s) covered (Norethindrone) are classified by the CAS Registry Number. In addition, where available this consumption is further analyzed by Application or End User sector.
CAS Number: 68-22-4
CAS_Synonyms: Norethindrone; 19-Norethisterone; 17a-Ethynyl-19-nortestosterone; 17-Hydroxy-19-nor-17a-pregn-4-en-20-yn-3-one
Equivalent EINECS: 200-681-6
The CAS Norethindrone World Consumption Reports gives 6 pages of data for each of about 200 countries, plus thousands of database tables and spreadsheets.
This report specifications: Pages: 2029; Spreadsheets: 5643; Tables: 5709; Diagrams: 575. Online Delivery 24-48 hours, plus DVD.
This is an entry level product which provides users with commercial intelligence on Norethindrone markets and industries about 200 countries. The report is formatted to give both a narrative description of the various matters covered as well as provide readers with the ability to directly use the Chapters (via Microsoft Word or compatible word processors) to produce their own reports and documentation. Experienced users will be able to use the spreadsheet and databases to generate highly detailed narrative reports, charts and graphics - as well as sophisticated business and commercial forecasts and models. The databases are provided in both Excel spreadsheets and an Access database. Explanatory notes are provided as word processor documents or in PDF formats.
As an entry level product the narrative is necessarily illustrative in its terminology and seeks to provide a basic degree of business logic and theory which indicates the rational applied in the forecasting and modelling methodology.
For more information visit http://www.researchandmarkets.com/research/8chckw/cas_norethindrone